131 related articles for article (PubMed ID: 14697442)
21. Impact of inter- and intra-observer variabilities of catheter reconstruction on multi-catheter interstitial brachytherapy of breast cancer patients.
Kallis K; Kaltsas T; Kreppner S; Lotter M; Strnad V; Fietkau R; Bert C
Radiother Oncol; 2019 Jun; 135():25-32. PubMed ID: 31015167
[TBL] [Abstract][Full Text] [Related]
22. The impact of uncertainties associated with MammoSite brachytherapy on the dose distribution in the breast.
Bensaleh S; Bezak E
J Appl Clin Med Phys; 2011 Nov; 12(4):3464. PubMed ID: 22089003
[TBL] [Abstract][Full Text] [Related]
23. Preliminary results and evaluation of MammoSite balloon brachytherapy for partial breast irradiation for pure ductal carcinoma in situ: a phase II clinical study.
Benitez PR; Streeter O; Vicini F; Mehta V; Quiet C; Kuske R; Hayes MK; Arthur D; Kuerer H; Freedman G; Keisch M; Dipetrillo T; Khan D; Hudes R
Am J Surg; 2006 Oct; 192(4):427-33. PubMed ID: 16978943
[TBL] [Abstract][Full Text] [Related]
24. Dosimetric comparisons between high dose rate interstitial and MammoSite balloon brachytherapy for breast cancer.
Major T; Niehoff P; Kovács G; Fodor J; Polgár C
Radiother Oncol; 2006 Jun; 79(3):321-8. PubMed ID: 16730085
[TBL] [Abstract][Full Text] [Related]
25. The effect of finite patient dimensions and tissue inhomogeneities on dosimetry planning of 192Ir HDR breast brachytherapy: a Monte Carlo dose verification study.
Pantelis E; Papagiannis P; Karaiskos P; Angelopoulos A; Anagnostopoulos G; Baltas D; Zamboglou N; Sakelliou L
Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1596-602. PubMed ID: 15817368
[TBL] [Abstract][Full Text] [Related]
26. Early European experience with the MammoSite radiation therapy system for partial breast brachytherapy following breast conservation operation in low-risk breast cancer.
Niehoff P; Ballardini B; Polgár C; Major T; Hammer J; Richetti A; Kovács G
Breast; 2006 Jun; 15(3):319-25. PubMed ID: 16765284
[TBL] [Abstract][Full Text] [Related]
27. A Contura catheter offers dosimetric advantages over a MammoSite catheter that increase the applicability of accelerated partial breast irradiation.
Wilder RB; Curcio LD; Khanijou RK; Eisner ME; Kakkis JL; Chittenden L; Agustin J; Lizarde J; Mesa AV; Ravera J; Tokita KM
Brachytherapy; 2009; 8(4):373-8. PubMed ID: 19736045
[TBL] [Abstract][Full Text] [Related]
28. Optimization of dose distributions for bifurcated coronary vessels treated with catheter-based photon and beta emitters using the simulated annealing algorithm.
Yue N; Roberts KB; Son H; Khosravi S; Pfau SE; Nath R
Med Phys; 2004 Sep; 31(9):2610-22. PubMed ID: 15487744
[TBL] [Abstract][Full Text] [Related]
29. A comparison between tandem and ovoids and interstitial gynecologic template brachytherapy dosimetry using a hypothetical computer model.
Hsu IC; Speight J; Hai J; Vigneault E; Phillips T; Pouliot J
Int J Radiat Oncol Biol Phys; 2002 Feb; 52(2):538-43. PubMed ID: 11872302
[TBL] [Abstract][Full Text] [Related]
30. Five-year results: the initial clinical trial of MammoSite balloon brachytherapy for partial breast irradiation in early-stage breast cancer.
Benitez PR; Keisch ME; Vicini F; Stolier A; Scroggins T; Walker A; White J; Hedberg P; Hebert M; Arthur D; Zannis V; Quiet C; Streeter O; Silverstein M
Am J Surg; 2007 Oct; 194(4):456-62. PubMed ID: 17826055
[TBL] [Abstract][Full Text] [Related]
31. Comparison of organ doses for patients undergoing balloon brachytherapy of the breast with HDR 192Ir or electronic sources using monte carlo simulations in a heterogeneous human phantom.
Mille MM; Xu XG; Rivard MJ
Med Phys; 2010 Feb; 37(2):662-71. PubMed ID: 20229875
[TBL] [Abstract][Full Text] [Related]
32. Dose perturbations due to contrast medium and air in mammosite treatment: an experimental and Monte Carlo study.
Cheng CW; Mitra R; Li XA; Das IJ
Med Phys; 2005 Jul; 32(7):2279-87. PubMed ID: 16121583
[TBL] [Abstract][Full Text] [Related]
33. Acute complications of MammoSite brachytherapy: a single institution's initial clinical experience.
Harper JL; Jenrette JM; Vanek KN; Aguero EG; Gillanders WE
Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):169-74. PubMed ID: 15629608
[TBL] [Abstract][Full Text] [Related]
34. Electromagnetic tracking (EMT) technology for improved treatment quality assurance in interstitial brachytherapy.
Kellermeier M; Herbolzheimer J; Kreppner S; Lotter M; Strnad V; Bert C
J Appl Clin Med Phys; 2017 Jan; 18(1):211-222. PubMed ID: 28291934
[TBL] [Abstract][Full Text] [Related]
35. The evaluation of a 2D diode array in “magic phantom” for use in high dose rate brachytherapy pretreatment quality assurance.
Espinoza A; Petasecca M; Fuduli I; Howie A; Bucci J; Corde S; Jackson M; Lerch ML; Rosenfelda AB
Med Phys; 2015 Feb; 42(2):663-73. PubMed ID: 25771556
[TBL] [Abstract][Full Text] [Related]
36. Dose-volume analysis for quality assurance of interstitial brachytherapy for breast cancer.
Vicini FA; Kestin LL; Edmundson GK; Jaffray DA; Wong JW; Kini VR; Chen PY; Martinez AA
Int J Radiat Oncol Biol Phys; 1999 Oct; 45(3):803-10. PubMed ID: 10524437
[TBL] [Abstract][Full Text] [Related]
37. A method for restricting intracatheter dwell time variance in high-dose-rate brachytherapy plan optimization.
Cunha A; Siauw T; Hsu IC; Pouliot J
Brachytherapy; 2016; 15(2):246-51. PubMed ID: 26727333
[TBL] [Abstract][Full Text] [Related]
38. Adaptation of the CVT algorithm for catheter optimization in high dose rate brachytherapy.
Poulin E; Fekete CA; Létourneau M; Fenster A; Pouliot J; Beaulieu L
Med Phys; 2013 Nov; 40(11):111724. PubMed ID: 24320432
[TBL] [Abstract][Full Text] [Related]
39. The MammoSite breast brachytherapy applicator: a review of technique and outcomes.
Dickler A; Kirk MC; Chu J; Nguyen C
Brachytherapy; 2005; 4(2):130-6. PubMed ID: 15893266
[TBL] [Abstract][Full Text] [Related]
40. Inverse planning for interstitial gynecologic template brachytherapy: truly anatomy-based planning.
Lessard E; Hsu IC; Pouliot J
Int J Radiat Oncol Biol Phys; 2002 Nov; 54(4):1243-51. PubMed ID: 12419454
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
